Tag: #synthetic-biology16 results
Scientists have created the first viruses designed by AI, focusing on bacteriophages that infect bacteria rather than humans. In laboratory tests, a cocktail of these viruses killed E. coli strains resistant to natural bacteriophages, while raising urgent biosecurity concerns.
Researchers at the University of Minnesota have developed SpudCell, the first synthetic life form capable of autonomous feeding, growth, and reproduction. The organism is built from approximately 200 basic molecules and mimics the simplicity of natural bacteria.
Columbia University team used generative AI to redesign E. coli ribosome, replacing all 382 isoleucines with alternatives, creating stable Ec19 strain with 19 amino acids. AI tools like AlphaFold2 and ProteinMPNN enabled iterative design-build-test for functional proteins. This marks first simplification of life's amino acid alphabet since LUCA.
Researchers used the Evo 1 and Evo 2 genome language models to generate complete bacteriophage genomes based on ΦX174. Experimental testing found 16 viable phages with substantial evolutionary novelty and targeted host-tropism characteristics.
Researchers used AI to engineer the first living organism with only 19 amino acids, defying nature's standard 20-amino acid rule. This synthetic life form lacks a fundamental building block of life. The breakthrough highlights AI's role in synthetic biology.
Scientists used AI to redesign E. coli's ribosome, eliminating isoleucine while preserving function, proving 19 amino acids suffice for key cellular machinery. Tools like ESM2 and AlphaFold2 enabled novel sequences beyond natural evolution. Full organism still uses 20, but this advances synthetic biology.
DARPA’s Biological Technologies Office (BTO) is expanding high-risk research across biological foundation models, battlefield medicine, and distributed biomanufacturing. Its programs aim to make biology programmable, designable, and manufacturable while strengthening national security and future bioeconomies.
Yiru Tech, a synthetic biology company, raised over 100 million RMB to scale production of bio-based leather. The company leverages AI for strain screening and fermentation optimization to achieve cost parity with traditional leather.
China is rapidly advancing its synthetic biology and biomanufacturing sector, utilizing AI-driven discovery to create 'cell factories.' These innovations range from artificial starch synthesis to advanced pharmaceutical development.
Synthetic biologists are engineering microbes to degrade pollutants like plastics, heavy metals, and explosives. By leveraging AI for enzyme design, these solutions aim to transform industrial waste into valuable materials, supporting a circular economy.